Blepharokeratoconjunctivitis
2 clinical trials · Condition
◉ Watch Blepharokeratoconjunctivitis
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects (NCT03383276) | Beijing Tongren Hospital | 2017-12-18 |
| Zylet vs TobraDex in Blepharokeratoconjunctivitis (NCT00447577) | Bausch & Lomb Incorporated | 2007-01-01 |
Track Blepharokeratoconjunctivitis automatically
Every clearance here is in the API, with alerts when new ones post.